Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo - PubMed (original) (raw)
Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo
Scott J Balsitis et al. Mol Cell Biol. 2003 Dec.
Abstract
Although the human papillomavirus (HPV) E7 oncogene is known to contribute to the development of human cervical cancer, the mechanisms of its carcinogenesis are poorly understood. The first identified and most recognized function of E7 is its binding to and inactivation of the retinoblastoma tumor suppressor (pRb), but at least 18 other biological activities have also been reported for E7. Thus, it remains unclear which of these many activities contribute to the oncogenic potential of E7. We used a Cre-lox system to abolish pRb expression in the epidermis of transgenic mice and compared the outcome with the effects of E7 expression in the same tissue at early ages. Mice lacking pRb in epidermis showed epithelial hyperplasia, aberrant DNA synthesis, and improper differentiation. In addition, Rb-deleted epidermis (i.e., epidermis composed of cells with Rb deleted) exhibited centrosomal abnormalities and failed to arrest the cell cycle in response to ionizing radiation. Transgenic mice expressing E7 in skin display the same range of phenotypes. In sum, few differences were detected between Rb-deleted epidermis and E7-expressing epidermis in young mice. However, when both E7 was expressed and Rb was deleted in the same tissue, increased hyperplasia and dysplasia were observed. These findings indicate that inactivation of the Rb pathway can largely account for E7's phenotypes at an early age, but that pRb-independent activities of E7 are detectable in vivo.
Figures
FIG. 1.
Cre-mediated inactivation of pRb in 21-day-old murine epidermis. (A) Schematic of the floxed Rb allele before and after recombination. Cre expression under the K14 promoter limits recombination to stratified squamous epithelia. (B) pRb immunohistochemistry of ear epidermal sections. (C) Quantification of pRb inactivation. Keratinocytes from Rbf/f or K14CreRbf/f sections stained for pRb were counted either as pRb positive (brown) or negative (blue).
FIG. 2.
Hyperplasia in E7-expressing and _Rb_-deleted epidermis. (A) BrdU immunohistochemistry of ear epidermal sections from mice injected with BrdU 1 h prior to sacrifice. (B) Quantification of BrdU incorporation. Basal and suprabasal cells were counted as BrdU positive (brown) or BrdU negative (blue), and the percentage of keratinocytes in each layer incorporating BrdU was calculated (basal cells are in contact with the basement membrane, but suprabasal cells are not). Increases in DNA synthesis in K14CreRbf/f (Cre-f/f) and K14E7 (E7) basal and suprabasal layers were statistically significant compared to Rbf/f (f/f) and K14CreRbf/wt (Cre-f/+) mice (P < 0.03). Differences between K14CreRbf/f and K14E7 mice were not statistically significant.
FIG. 3.
Disruption of DNA damage-induced cell cycle arrest by E7 expression or Rb deletion. Mice were exposed to 0 or 5 Gy of ionizing radiation 24 h prior to BrdU injection and sacrificed 1 h after BrdU administration. Epidermal sections were stained for BrdU incorporation and counted as in Fig. 2. Only Rbf/f (f/f) and K14CreRbf/wt (Cre-f/+) mice exhibited significant decreases in BrdU incorporation in response to ionizing radiation (P < 0.05). Cre-f/f, _K14CreRb_f/f mice; E7, K14E7 mice.
FIG. 4.
E7 expression or pRb inactivation disrupts epithelial differentiation. Ear epidermal sections of K14E7, K14CreRbf/f, and control mice were stained for the basal layer marker K14 (red) and the suprabasal layer marker K10 (green) and then counterstained with DAPI. For K10-stained sections, the white line represents the basement membrane.
FIG. 5.
Increased phenotype severity in K14E7K14CreRbf/f mice and phenotypic variation between epidermal sites. Hematoxylin-and-eosin-stained sections from dorsal skin and ear of 21-day-old mice are shown. K14E7 and K14CreRbf/f mice have pronounced hyperplasia in ear epidermis but relatively little hyperplasia in dorsal skin epidermis. K14E7K14CreRbf/f mice, however, exhibit pronounced hyperplasia at both epidermal sites. Also shown are examples of dysplastic lesions common in K14E7K14CreRbf/f mice but not seen in other genotypes.
FIG. 6.
Centrosome abnormalities in E7-expressing and _Rb_-deleted epidermis. Ear epidermal sections from 21-day-old animals were stained for gamma-tubulin and counterstained with DAPI. The fraction of cells containing >2 centrosomes was counted for three to seven mice per genotype. K14E7, K14CreRbf/f, and K14E7K14CreRbf/f sections all had increases over Rbf/f sections (P < 0.05), but the former three genotypes did not differ from one another.
Similar articles
- Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.
Gulliver GA, Herber RL, Liem A, Lambert PF. Gulliver GA, et al. J Virol. 1997 Aug;71(8):5905-14. doi: 10.1128/JVI.71.8.5905-5914.1997. J Virol. 1997. PMID: 9223480 Free PMC article. - Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.
Herber R, Liem A, Pitot H, Lambert PF. Herber R, et al. J Virol. 1996 Mar;70(3):1873-81. doi: 10.1128/JVI.70.3.1873-1881.1996. J Virol. 1996. PMID: 8627712 Free PMC article. - Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.
Balsitis S, Dick F, Lee D, Farrell L, Hyde RK, Griep AE, Dyson N, Lambert PF. Balsitis S, et al. J Virol. 2005 Sep;79(17):11392-402. doi: 10.1128/JVI.79.17.11392-11402.2005. J Virol. 2005. PMID: 16103190 Free PMC article. - Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM, Münger K, Romanczuk H, Scheffner M, Huibregtse JM. Howley PM, et al. Princess Takamatsu Symp. 1991;22:239-48. Princess Takamatsu Symp. 1991. PMID: 1668886 Review. - Molecular mechanism of carcinogenesis by human papillomavirus-16.
Ishiji T. Ishiji T. J Dermatol. 2000 Feb;27(2):73-86. doi: 10.1111/j.1346-8138.2000.tb02126.x. J Dermatol. 2000. PMID: 10721654 Review.
Cited by
- Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan.
Takahashi R, Osumi H, Wakatsuki T, Yamamoto N, Taguchi S, Nakayama I, Ooki A, Ogura M, Takahari D, Chin K, Yamaguchi K, Shinozaki E. Takahashi R, et al. Int J Clin Oncol. 2024 Aug;29(8):1161-1172. doi: 10.1007/s10147-024-02540-0. Epub 2024 May 31. Int J Clin Oncol. 2024. PMID: 38819609 - Metabolic Control by DNA Tumor Virus-Encoded Proteins.
Prusinkiewicz MA, Mymryk JS. Prusinkiewicz MA, et al. Pathogens. 2021 May 6;10(5):560. doi: 10.3390/pathogens10050560. Pathogens. 2021. PMID: 34066504 Free PMC article. Review. - Restoring the DREAM Complex Inhibits the Proliferation of High-Risk HPV Positive Human Cells.
James CD, Saini S, Sesay F, Ko K, Felthousen-Rusbasan J, Iness AN, Nulton T, Windle B, Dozmorov MG, Morgan IM, Litovchick L. James CD, et al. Cancers (Basel). 2021 Jan 27;13(3):489. doi: 10.3390/cancers13030489. Cancers (Basel). 2021. PMID: 33513914 Free PMC article. - Finding the hot spot: identifying immune sensitive gastrointestinal tumors.
De Souza ALPB. De Souza ALPB. Transl Gastroenterol Hepatol. 2020 Oct 5;5:48. doi: 10.21037/tgh.2019.12.11. eCollection 2020. Transl Gastroenterol Hepatol. 2020. PMID: 33073043 Free PMC article. Review. - Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
Morgan EL, Macdonald A. Morgan EL, et al. Viruses. 2020 Sep 3;12(9):977. doi: 10.3390/v12090977. Viruses. 2020. PMID: 32899142 Free PMC article. Review.
References
- Bickenbach, J. R., and E. Chism. 1998. Selection and extended growth of murine epidermal stem cells in culture. Exp. Cell Res. 244:184-195. - PubMed
- Boyer, S. N., D. E. Wazer, and V. Band. 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56:4620-4624. - PubMed
- Chellappan, S., V. B. Kraus, B. Kroger, K. Munger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549-4553. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- T32 GM007215/GM/NIGMS NIH HHS/United States
- CA 66980/CA/NCI NIH HHS/United States
- CA 22443/CA/NCI NIH HHS/United States
- T32 GM 07215/GM/NIGMS NIH HHS/United States
- CA 84227/CA/NCI NIH HHS/United States
- P01 CA022443/CA/NCI NIH HHS/United States
- R01 CA066980/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases